Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference – Biotech Investments
Kuros Biosciences AG / Key word(s): Conference Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference 01.02.2024 / 07:00 CET/CEST Schlieren (Zurich), Switzerland, February